These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10729738)

  • 1. Cognitive-motor performance of methadone-maintained patients.
    Specka M; Finkbeiner T; Lodemann E; Leifert K; Kluwig J; Gastpar M
    Eur Addict Res; 2000 Mar; 6(1):8-19. PubMed ID: 10729738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
    Soyka M; Hock B; Kagerer S; Lehnert R; Limmer C; Kuefner H
    J Clin Psychopharmacol; 2005 Oct; 25(5):490-3. PubMed ID: 16160628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation.
    Bracken BK; Trksak GH; Penetar DM; Tartarini WL; Maywalt MA; Dorsey CM; Lukas SE
    Drug Alcohol Depend; 2012 Sep; 125(1-2):132-9. PubMed ID: 22552256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of the effects of working memory training in methadone maintenance patients.
    Rass O; Schacht RL; Buckheit K; Johnson MW; Strain EC; Mintzer MZ
    Drug Alcohol Depend; 2015 Nov; 156():38-46. PubMed ID: 26404954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers.
    Kleykamp BA; Vandrey RG; Bigelow GE; Strain EC; Mintzer MZ
    Am J Drug Alcohol Abuse; 2015 May; 41(3):251-6. PubMed ID: 25584897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
    Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
    J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in methadone maintenance patients.
    Mintzer MZ; Stitzer ML
    Drug Alcohol Depend; 2002 Jun; 67(1):41-51. PubMed ID: 12062778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological performance of methadone-maintained opiate users.
    Wang GY; Wouldes TA; Kydd R; Jensen M; Russell BR
    J Psychopharmacol; 2014 Aug; 28(8):789-99. PubMed ID: 24920133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less driving impairment on buprenorphine than methadone in drug-dependent patients?
    Soyka M; Horak M; Dittert S; Kagerer S
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):527-8. PubMed ID: 11748323
    [No Abstract]   [Full Text] [Related]  

  • 11. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
    Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
    Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function is largely intact in methadone maintenance treatment patients.
    Elkana O; Adelson M; Doniger GM; Sason A; Peles E
    World J Biol Psychiatry; 2019 Mar; 20(3):219-229. PubMed ID: 28610451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse liability of flunitrazepam among methadone-maintained patients.
    Farré M; Terán MT; Roset PN; Mas M; Torrens M; Camí J
    Psychopharmacology (Berl); 1998 Dec; 140(4):486-95. PubMed ID: 9888625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence.
    Brooks DJ; Vosburg SK; Evans SM; Levin FR
    J Addict Dis; 2006; 25(4):15-25. PubMed ID: 17088222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of methadone maintenance in clinical opiate dependence].
    Gössling HW; Gunkel S; Wegener U; Woiton V
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6):278-85. PubMed ID: 9676423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective attention and drug related attention bias in methadone maintenance patients.
    Nejati M; Nejati V; Mohammadi MR
    Acta Med Iran; 2011; 49(12):814-7. PubMed ID: 22174171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.